Production (Stage)
BiomX Inc.
PHGE
$0.50
-$0.017-3.29%
AMEX
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | -8.06M | -17.73M | -8.71M | -26.25M | -37.14M |
Total Depreciation and Amortization | 1.81M | 1.80M | 1.09M | 991.00K | 877.00K |
Total Amortization of Deferred Charges | -- | -- | 114.00K | 236.00K | 499.00K |
Total Other Non-Cash Items | -26.77M | -18.06M | -23.44M | -4.56M | 9.37M |
Change in Net Operating Assets | -1.31M | -2.99M | -5.99M | -5.17M | -1.21M |
Cash from Operations | -34.34M | -36.98M | -36.93M | -34.76M | -27.60M |
Capital Expenditure | -30.00K | -30.00K | -26.00K | -48.00K | -40.00K |
Sale of Property, Plant, and Equipment | 133.00K | 82.00K | 73.00K | 64.00K | 1.00K |
Cash Acquisitions | 0.00 | 663.00K | 663.00K | 663.00K | 663.00K |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | 0.00 | 0.00 | 0.00 |
Cash from Investing | 103.00K | 715.00K | 710.00K | 679.00K | 624.00K |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | 0.00 | -10.75M | -12.07M | -13.35M | -14.58M |
Issuance of Common Stock | 12.00M | 25.00K | 25.00K | 25.00K | 6.04M |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | 0.00 | 21.27M | 21.27M | 21.27M | 21.27M |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -689.00K | 27.83M | 28.23M | 28.19M | 28.10M |
Cash from Financing | 11.31M | 38.37M | 37.45M | 36.14M | 40.82M |
Foreign Exchange rate Adjustments | 35.00K | 1.00K | 32.00K | -11.00K | -38.00K |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -22.89M | 2.11M | 1.26M | 2.05M | 13.81M |